Artificial Intelligence helps identify Diabetic Retinopathy and Clinically Significant Diabetic Macular Edema

July 30, 2019. Chicago, IL: The results of a prospective study, titled “Artificial Intelligence Screening for Diabetic Retinopathy: Analysis from a Pivotal Multi-center Prospective Clinical Trial,” were presented at the 37TH American Society of Retina Specialists Annual Meeting by Jennifer Lim, MD (professor of ophthalmology and director of the Retina Service at University of Illinois

Eyenuk, Inc. transitioning to a new logo

Eyenuk’s logo was originally conceived back in early 2013 , to give the viewer the impression of staring at a “real” 3-dimensional eye, while giving it an orange hue to be consistent with the Eyenuk branding. The logo’s font was chosen to serve as a logo on its own when required. Our old logo has

Eyenuk successfully clears HIPAA audit by A-Lign

Eyenuk Inc., a global artificial intelligence (AI) medical technology company, is pleased to announce that it has successfully cleared an independent HIPAA audit. As a leader in real-world AI eye screening for autonomous disease detection, the team at Eyenuk Inc. understands and embraces the responsibility to keep patient data both private and secure, and they